3-(N-(4-chlorophenyl)-N-methylsulfamoyl)benzoic acid | 361473-14-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(N-(4-chlorophenyl)-N-methylsulfamoyl)benzoic acid
• 英文别名: 3-{[(4-Chlorophenyl)(methyl)amino]sulfonyl}benzoic acid；3-[(4-chlorophenyl)-methylsulfamoyl]benzoic acid
• CAS: 361473-14-5
• 化学式: C₁₄H₁₂ClNO₄S
• 分子量: 325.773
• InChiKey: UHCHRXFDIKYBQU-UHFFFAOYSA-N

物化性质

• 沸点：
  535.5±60.0 °C(Predicted)
• 密度：
  1.470±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  21
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  83.1
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-(N-(4-chlorophenyl)-N-methylsulfamoyl)benzoic acid 在 草酰氯 作用下， 以 DMF (N,N-dimethyl-formamide) 、 二氯甲烷 为溶剂， 以100%的产率得到3-{ [ (4-CHLOROPHENYL) (methyl) amino] sulfonyl} benzoyl chloride
  参考文献：
  名称：

  [EN] ANTIBACTERIAL BENZOIC ACID DERIVATIVES
  [FR] DERIVES D'ACIDE BENZOIQUE ANTIBACTERIENS

  摘要：

  公开号：

  WO2004018461A3
• 作为产物：
  描述：

  苯甲酸 在 吡啶 作用下， 以 乙酸乙酯 为溶剂， 反应 4.0h， 生成 3-(N-(4-chlorophenyl)-N-methylsulfamoyl)benzoic acid
  参考文献：
  名称：

  Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors

  摘要：

  Inhibitors of sirtuin-2 deacetylase (SIRT2) have been shown to be protective in various models of Huntington's disease (HD) by decreasing polyglutamine aggregation, a hallmark of HD pathology. The present study was directed at optimizing the potency of SIRT2 inhibitors containing the neuroprotective sulfobenzoic acid scaffold and improving their pharmacology. To achieve that goal, 176 analogues were designed, synthesized, and tested in deacetylation assays against the activities of major human sirtuins SIRT1-3. This screen yielded 15 compounds with enhanced potency for SIRT2 inhibition and 11 compounds having SIRT2 inhibition equal to reference compound AK-1. The newly synthesized compounds also demonstrated higher SIRT2 selectivity over SIRT1 and SIRT3. These candidates were subjected to a dose-response bioactivity assay, measuring an increase in alpha-tubulin K40 acetylation in two neuronal cell lines, which yielded five compounds bioactive in both cell lines and eight compounds bioactive in at least one of the cell lines tested. These bioactive compounds were subsequently tested in a tertiary polyglutamine aggregation assay, which identified five inhibitors. ADME properties of the bioactive SIRT2 inhibitors were assessed, which revealed a significant improvement of the pharmacological properties of the new entities, reaching closer to the goal of a clinically-viable candidate. (C) 2014 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2014.02.003

文献信息

• [EN] BENZAMIDE COMPOUNDS AND RELATED METHODS OF USE<br/>[FR] COMPOSÉS BENZAMIDE ET LEURS PROCÉDÉS D'UTILISATION CONNEXES
  申请人：UNIV NORTHWESTERN

  公开号：WO2014100833A1

  公开（公告）日：2014-06-26

  Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.

  苯甲酰胺化合物及其衍生物，可用于选择性抑制SIRT2酶和/或在亨廷顿病的治疗中用于治疗用途。
• Antibacterial benzoic acid derivatives
  申请人：——

  公开号：US20040142981A1

  公开（公告）日：2004-07-22

  The present invention relates to antibacterial agents that are useful for sterilization, sanitation, antisepsis, disinfection, and treatment of antibacterial infections in mammals.

  本发明涉及一种抗菌剂，可用于哺乳动物的消毒、卫生、消毒、抗菌感染的治疗。
• Benzamide Compounds and Related Methods of Use
  申请人：Northwestern University

  公开号：US20150025235A1

  公开（公告）日：2015-01-22

  Benzamide compounds and derivatives thereof, as can be used for selective inhibition of the SIRT2 enzyme and/or therapeutic use in the treatment of Huntington's disease.

  苯甲酰胺化合物及其衍生物可用于选择性抑制SIRT2酶和/或治疗亨廷顿病。
• Bacterial translation inhibitors, 1-acylindazol-3-ols as anthranilic acid mimics
  作者：Cory Stiff、David R. Graber、Atli Thorarensen、Brian D. Wakefield、Keith R. Marotti、Earline P. Melchior、Michael T. Sweeney、Fusen Han、Douglas C. Rohrer、Gary E. Zurenko、Donna L. Romero

  DOI：10.1016/j.bmcl.2007.08.041

  日期：2008.12

  The discovery and initial optimization of a novel anthranilic acid derived class of antibacterial agents has been described in a recent series of papers. This paper describes the discovery of 1-acylindazol-3-ols as a novel bioisostere of an anthranilic acid. The synthesis and structure-activity relationships of the indazol bioisosteres are described herein. (C) 2008 Published by Elsevier Ltd.
• 3-(N-Arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)
  作者：Soo Hyuk Choi、Luisa Quinti、Aleksey G. Kazantsev、Richard B. Silverman

  DOI：10.1016/j.bmcl.2012.02.089

  日期：2012.4

  Inhibition of sirtuin 2 (SIRT2) is known to be protective against the toxicity of disease proteins in Parkinson's and Huntington's models of neurodegeneration. Previously, we developed SIRT2 inhibitors based on the 3-(N-arylsulfamoyl)benzamide scaffold, including3-(N-(4-bromophenyl)sulfamoyl)-N-(4-bromophenyl) benzamide(C2-8, 1a), which demonstrated neuroprotective effects in a Huntington's mouse model, but had low potency of SIRT2 inhibition. Here we report that N-methylation of 1a greatly increases its potency and results in excellent selectivity for SIRT2 over SIRT1 and SIRT3 isoforms. Structure-activity relationships observed for 1a analogs and docking simulation data suggest that the para-substituted amido moiety of these compounds could occupy two potential hydrophobic binding pockets in SIRT2. These results provide a direction for the design of potent drug-like SIRT2 inhibitors. (C) 2012 Elsevier Ltd. All rights reserved.